A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.
Single-Dose Dengue Vaccine Effective, Regardless of Baseline Serostatus
One dose of the live, attenuated, tetravalent dengue vaccine Butantan-DV prevented symptomatic disease through 2-year follow-up, regardless of baseline serostatus, a phase III, placebo-controlled study
February 1, 2024